pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,995 catalysts · 5,720 phase readout · 2,311 8k filing · 275 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 0 catalysts2026-08-04: 0 catalysts2026-08-05: 0 catalysts2026-08-06: 0 catalysts2026-08-07: 2 catalysts2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 7 catalysts2026-08-11: 6 catalysts2026-08-12: 9 catalysts2026-08-13: 10 catalysts2026-08-14: 3 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 5 catalysts2026-10-28: 6 catalysts2026-10-29: 14 catalysts2026-10-30: 3 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: earnings×type: recall×type: phase readout×clear all
type
  • phase readout5,720
  • 8k filing2,311
  • earnings275
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

45
›COMPLETEDphase readoutNCT02721316: Outpatient Nurse Monitoring Under the Prevention of Recurrent Suicidal

Sponsor: University Hospital, Montpellier. Phase: NA. Conditions: Mood Disorder, Reactive Depression

full page →ctgov ↗
›COMPLETEDphase readoutNCT05360706: Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia B

Sponsor: CSL Behring. Phase: . Conditions: Hemophilia B

full page →ctgov ↗
›RECRUITINGphase readoutNCT07142304: The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study

Sponsor: Luminate Medical, Inc.. Phase: NA. Conditions: Chemotherapy Induced Peripheral Neuropathy (CIPN)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07159204: Polymeric Micellar Paclitaxel-Based Combination Therapy for Advanced Biliary Tract Cancer

Sponsor: Peking Union Medical College Hospital. Phase: PHASE2. Conditions: Biliary Tract Cancer (BTC)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06899204: Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.

Sponsor: Pfizer. Phase: . Conditions: Atopic Dermatitis, Atopic Dermatitis, Unspecified, Dermatitis, Atopic

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07720804: Kinetics of C-Reactive Protein in Giant Cell Arteritis Following Glucocorticoid Initiation: A Pilot Study (GIDEON)

Sponsor: University Hospital, Limoges. Phase: NA. Conditions: Giant Cell Arteritis (GCA)

full page →ctgov ↗
›COMPLETEDphase readoutNCT03455504: Venetoclax Add in Combination With Fludarabine, Cyratabine and Idarubicine in Induction for Acute Myelid Leukemia

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto. Phase: PHASE2. Conditions: Acute Myeloid Leukemia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02131584: Ruxolitinib Phosphate in Reducing Fatigue in Patients With Chronic Lymphocytic Leukemia

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Chronic Lymphocytic Leukemia

full page →ctgov ↗
›COMPLETEDphase readoutNCT04563884: Validity of the French Version of Deafness Questionnaires for Children and Adolescents

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Deafness

full page →ctgov ↗
›COMPLETEDphase readoutNCT03413384: To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia

Sponsor: BrainX Corporation. Phase: PHASE2. Conditions: Parkinson's Disease Dementia

full page →ctgov ↗
›COMPLETEDphase readoutNCT04494984: A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.

Sponsor: Inmunova S.A.. Phase: PHASE2. Conditions: COVID-19

full page →ctgov ↗
›RECRUITINGphase readoutNCT07453784: Study to Evaluate Pharmacokinetics, Relative Bioavailability, Palatability of Obefazimod Minitablet Formulation

Sponsor: Abivax S.A.. Phase: PHASE1. Conditions: Healthy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07456384: Sensory Stimulation Program Delivered by Family Members of Brain-injured Patients in Critical Care: Effect on Relatives' Post-traumatic Stress

Sponsor: CHU de Reims. Phase: NA. Conditions: Stress Disorder, Post-traumatic

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07679633: App-based Motor Skills Intervention in Primary School and Home Settings

Sponsor: Tampere University. Phase: NA. Conditions: Healthy, Motor Activity

full page →ctgov ↗
›COMPLETEDphase readoutNCT07674472: Impact of Climate Change Education on Nursing Students' Awareness

Sponsor: Koç University. Phase: . Conditions: Climate Change, Nursing Education, Peer Counseling

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07456839: A Mutiple-dose Study of IBI3033 in Healthy Participants

Sponsor: Innovent Biologics (Suzhou) Co. Ltd.. Phase: PHASE1. Conditions: Healthy Participants

full page →ctgov ↗
›COMPLETEDphase readoutNCT07333157: Effects of Wearable Passive Back Support Suit on Back Pain in Caregivers

Sponsor: Samsung Medical Center. Phase: NA. Conditions: Back Pain, Exoskeleton Device

full page →ctgov ↗
›COMPLETEDphase readoutNCT06990828: Frenkel Exercises in Geriatric Balance and Fall Prevention

Sponsor: Okan University. Phase: NA. Conditions: Healthy Aging

full page →ctgov ↗
›COMPLETEDphase readoutNCT04557228: ADAM17 and Vascular Function in Diabetes

Sponsor: University of Missouri-Columbia. Phase: NA. Conditions: Diabetes Mellitus, Type 2

full page →ctgov ↗
›RECRUITINGphase readoutNCT05925465: Maxillary and Mandibular Nerve Block

Sponsor: Mansoura University. Phase: NA. Conditions: Analgesia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06367465: Feasibility and Acceptability of HCV Treatment in Pregnancy

Sponsor: Washington University School of Medicine. Phase: . Conditions: Hepatitis C, Pregnancy Complications

full page →ctgov ↗
›RECRUITINGphase readoutNCT07495865: Post-market Clinical Follow-up (PMCF) Study of Safety and Performance of 502-01 AnGelHA 2

Sponsor: Glyance. Phase: . Conditions: Wrinkles

full page →ctgov ↗
›COMPLETEDphase readoutNCT07654036: Preliminary Evaluation of a Large Language Model-Based Tool for Complex Surgical Decision Support in Lung Cancer

Sponsor: Peking University People's Hospital. Phase: NA. Conditions: Large Language Models, Lung Cancer (NSCLC)

full page →ctgov ↗
›COMPLETEDphase readoutNCT07436936: OPTIPROT, Targeted Precision Nutrition for Protein Needs in Ageing

Sponsor: Fundació Eurecat. Phase: . Conditions: Healthy Aging, Nutritional Status, Dietary Protein, Muscle Weakness

full page →ctgov ↗
›RECRUITINGphase readoutNCT06975111: Focusing on the Menopausal Transition to Improve Mid-Life Women's Health

Sponsor: University of Colorado, Denver. Phase: PHASE2. Conditions: Menopause, Menopause Hot Flashes, Menopause Related Conditions, Cardiovascular

full page →ctgov ↗
›WITHDRAWNphase readoutNCT05165511: Families, Responsibility, Education, Support, and Health for Executive Function

Sponsor: University of California, San Diego. Phase: NA. Conditions: Overweight and Obesity, Attention-Deficit Hyperactivity Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05687344: Intensive Postpartum Antihypertensive Treatment

Sponsor: Medical College of Wisconsin. Phase: PHASE3. Conditions: Hypertensive Disorder of Pregnancy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07698834: Splanchnic Perfusion Monitoring in Septic Shock Using Doppler Ultrasound

Sponsor: Assiut University. Phase: . Conditions: Septic Shock

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07697534: Two-Year Follow-up Study on Children Exposed to Trauma

Sponsor: Istanbul University. Phase: . Conditions: Post-traumatic Stress Disorder (PTSD), Complex Post-Traumatic Stress Disorder (CPTSD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07406334: A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months of Age Receiving a Single Booster Dose

Sponsor: GlaxoSmithKline. Phase: PHASE1. Conditions: Pneumonia, Bacterial

full page →ctgov ↗
›COMPLETEDphase readoutNCT06038344: Influence of a Gluten Free Food Guide on Diet Quality and Adherence to the GFD in Youth With Celiac Disease

Sponsor: University of Alberta. Phase: NA. Conditions: Celiac Disease in Children, Gluten Enteropathy, Diet; Deficiency, Adherence, Treatment

full page →ctgov ↗
›RECRUITINGphase readoutNCT07428044: A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer Stage II, Non-Small Cell Lung Cancer Stage IIIA, Non-Small Cell Lung Cancer Stage IIIB

full page →ctgov ↗
›COMPLETEDphase readoutNCT05549934: Ritlecitinib for Cicatricial Alopecia

Sponsor: Emma Guttman. Phase: PHASE2. Conditions: Cicatricial Alopecia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07365644: Prophylactic ANTicoagulation With HEparine in Critically Ill Patients With Renal Impairment

Sponsor: Centre Hospitalier le Mans. Phase: . Conditions: Prophylactic Anticoagulation

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07714434: Relationship Between Visuospatial Attention and Balance

Sponsor: Istanbul Gedik University. Phase: . Conditions: Balance Assessment, Visuospatial/Perceptual Abilities, EEG Brain Oscillations

full page →ctgov ↗
›RECRUITINGphase readoutNCT06261034: A Study of Sex Differences in Neurocirculatory Control

Sponsor: Mayo Clinic. Phase: . Conditions: Obstructive Sleep Apnea

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07450534: The Practicality and Utility of Measured vs Estimated GFR in adCKD

Sponsor: Manchester University NHS Foundation Trust. Phase: . Conditions: Chronic Kidney Disease (Stages 4 and 5), Chronic Kidney Disease 5D

full page →ctgov ↗
›RECRUITINGphase readoutNCT07670234: Dietary Supplements Among Cancer Patients: Tolerance, Impact on Medications, and Potential Drug Interactions

Sponsor: Centre Mohammed VI de la Recherche et de l'Innovation (CM6RI). Phase: . Conditions: Cancer (Solid Tumors), Interaction Drug Food

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07522034: Effects of Stress Ball and Hand Massage on Vital Signs, Anxiety, and Pain During Eye Surgery

Sponsor: Mehmet Gunay Uyar. Phase: NA. Conditions: Anxiety, Ophthalmologic Surgical Procedure, Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT06743009: Metabolic Effects of the Exercise-metabolite Lac-Phe

Sponsor: University of Aarhus. Phase: NA. Conditions: Healthy Overweight/Obese

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06190509: Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study

Sponsor: LimmaTech Biologics AG. Phase: PHASE1. Conditions: Recurrent Vulvovaginal Candidiasis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06868732: Evaluation of JSKN016 Combination Therapy in Subjects With NSCLC

Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd. Phase: PHASE1. Conditions: Advanced Non-small Cell Lung Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04882098: A Study of Guselkumab in Participants With Active Psoriatic Arthritis

Sponsor: Janssen Research & Development, LLC. Phase: PHASE3. Conditions: Arthritis, Psoriatic

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06236087: Overdose Prevention Centers and Behavioral Health

Sponsor: NYU Langone Health. Phase: . Conditions: Overdose

full page →ctgov ↗
›RECRUITINGphase readoutNCT07473687: Feasibility Study of Non-Contact Imaging-Based Physiological Monitoring in the Operating Room

Sponsor: Taipei Veterans General Hospital, Taiwan. Phase: . Conditions: Cholecystitis, Liver Neoplasms, Cholelithiasis, Inguinal Hernia

full page →ctgov ↗
← prev
page 120 of 120
next →